Related Experiment Video
Updated: Jan 13, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
KIF14 in cancer biology: implications for diagnosis and therapy
Ashok Kumar Bishoyi1, Shaker Al-Hasnaawei2,3, Subbulakshmi Ganesan4
1Department of Microbiology, Faculty of Science, Marwadi University Research Center, Marwadi University, Rajkot, Gujarat, India. ashokkumarbishoyi2@gmail.com.
Abstract:
Kinesin family member 14 (KIF14), a microtubule-associated motor protein, plays a crucial role in cytoskeletal dynamics, intracellular transport, and cell division. Oncological studies have consistently reported KIF14 overexpression across various cancers, including breast, ovarian, lung, liver, and brain tumors, associating it with poor clinical outcomes, increased tumor aggressiveness, and resistance to conventional therapies. This review comprehensively analyzed the involvement of KIF14 in cancer progression, particularly its roles in cell cycle regulation, mitotic spindle formation, and oncogenic signaling pathways. Additionally, the molecular mechanisms underlying its tumorigenic effects, its potential as a prognostic biomarker, and its viability as a therapeutic target are explored. The expanding understanding of KIF14's oncogenic functions present promising opportunities for developing novel therapeutic strategies aimed at this key regulator of tumor growth and metastasis, addressing the urgent need for treatments targeting aggressive and therapy-resistant malignancies.
Insights
Kinesin family member 14 (KIF14) is overexpressed in many cancers, driving tumor growth and resistance to therapy. Targeting KIF14 offers a promising strategy for treating aggressive and hard-to-treat malignancies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Kinesin family member 14 (KIF14) is a motor protein vital for cell division and intracellular transport.
- KIF14 overexpression is linked to poor prognosis and therapy resistance in multiple cancers.
- Its specific roles in cancer progression require comprehensive analysis.
Purpose of the Study:
- To review the involvement of KIF14 in cancer progression.
- To explore the molecular mechanisms of KIF14's tumorigenic effects.
- To evaluate KIF14 as a prognostic biomarker and therapeutic target.
Main Methods:
- Comprehensive literature review of oncological studies on KIF14.
- Analysis of KIF14's role in cell cycle regulation and mitotic spindle formation.
- Exploration of KIF14's involvement in oncogenic signaling pathways.
Main Results:
- KIF14 overexpression is a common feature in breast, ovarian, lung, liver, and brain cancers.
- KIF14 contributes to tumor aggressiveness, poor clinical outcomes, and therapeutic resistance.
- Its functions are implicated in cell cycle dysregulation and aberrant mitotic spindle assembly.
Conclusions:
- KIF14 is a significant driver of tumor growth and metastasis.
- KIF14 holds potential as a prognostic biomarker for cancer patients.
- Targeting KIF14 presents a promising therapeutic avenue for aggressive cancers.
More Related Videos
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
Mitogens and the Cell Cycle
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...